NCT01890993View on ClinicalTrials.gov

Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe

CompletedOBSERVATIONAL
Enrollment

952

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

liraglutide

Anonymised patient level data will be collected by the patients' own general practitioner and electronic case report form (eCRF) will be used to capture the data.

Trial Locations (4)

28033

Madrid

55127

Mainz

92932

Paris La Défense Cedex

RH11 9RT

Crawley

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY